136 related articles for article (PubMed ID: 18729011)
1. The role of genetic association studies in identifying new drug targets.
Lowe JA; Jones P; Wilson DM
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):603-5. PubMed ID: 18729011
[No Abstract] [Full Text] [Related]
2. Genomics in drug discovery: the best things come to those who wait.
Bansal AT; Barnes MR
Curr Opin Drug Discov Devel; 2008 May; 11(3):303-11. PubMed ID: 18428083
[TBL] [Abstract][Full Text] [Related]
3. Systems biology in drug discovery.
Butcher EC; Berg EL; Kunkel EJ
Nat Biotechnol; 2004 Oct; 22(10):1253-9. PubMed ID: 15470465
[TBL] [Abstract][Full Text] [Related]
4. Functional peptides by genome reverse engineering.
Grigorov MG; van Bladeren PJ
Curr Opin Drug Discov Devel; 2007 May; 10(3):341-6. PubMed ID: 17554861
[TBL] [Abstract][Full Text] [Related]
5. Systems cell biology based on high-content screening.
Giuliano KA; Johnston PA; Gough A; Taylor DL
Methods Enzymol; 2006; 414():601-19. PubMed ID: 17110213
[TBL] [Abstract][Full Text] [Related]
6. Identification of G-protein-coupled receptors involved in inflammatory disease by genetic association studies.
Pettipher R; Mangion J; Hunter MG; Mackay I
Curr Opin Pharmacol; 2005 Aug; 5(4):412-7. PubMed ID: 15955737
[TBL] [Abstract][Full Text] [Related]
7. A systems biology approach to drug discovery.
Zhu J; Zhang B; Schadt EE
Adv Genet; 2008; 60():603-35. PubMed ID: 18358334
[TBL] [Abstract][Full Text] [Related]
8. Network-centered view of coronary artery disease.
Bennett BJ; Romanoski CE; Lusis AJ
Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1095-103. PubMed ID: 18035925
[TBL] [Abstract][Full Text] [Related]
9. Embracing complexity in drug discovery.
Gund P; Maliski E; Brown F
Curr Opin Drug Discov Devel; 2007 May; 10(3):252-3. PubMed ID: 17554850
[No Abstract] [Full Text] [Related]
10. The increasing importance of genetic variation in drug discovery and development.
Labaudinière R
Curr Opin Mol Ther; 2002 Dec; 4(6):559-64. PubMed ID: 12596357
[TBL] [Abstract][Full Text] [Related]
11. Gene regulation in the postgenomic era: technology takes the wheel.
Dunn RK; Kingston RE
Mol Cell; 2007 Dec; 28(5):708-14. PubMed ID: 18082595
[TBL] [Abstract][Full Text] [Related]
12. Disease-specific target selection: a critical first step down the right road.
Roses AD; Burns DK; Chissoe S; Middleton L; St Jean P
Drug Discov Today; 2005 Feb; 10(3):177-89. PubMed ID: 15708532
[TBL] [Abstract][Full Text] [Related]
13. Network pharmacology: the next paradigm in drug discovery.
Hopkins AL
Nat Chem Biol; 2008 Nov; 4(11):682-90. PubMed ID: 18936753
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling in drug discovery and development.
Stratowa C; Wilgenbus KK
Curr Opin Mol Ther; 1999 Dec; 1(6):671-9. PubMed ID: 19629863
[TBL] [Abstract][Full Text] [Related]
15. Systems biology. Attractors and democratic dynamics.
Bar-Yam Y; Harmon D; de Bivort B
Science; 2009 Feb; 323(5917):1016-7. PubMed ID: 19229023
[No Abstract] [Full Text] [Related]
16. Druggable targets and targeted drugs: enhancing the development of new therapeutics.
Billingsley ML
Pharmacology; 2008; 82(4):239-44. PubMed ID: 18802381
[TBL] [Abstract][Full Text] [Related]
17. Quantitative proteomics for drug toxicity.
Gao Y; Holland RD; Yu LR
Brief Funct Genomic Proteomic; 2009 Mar; 8(2):158-66. PubMed ID: 19351682
[TBL] [Abstract][Full Text] [Related]
18. Systems biology for biotechnological innovation.
Alberghina L
J Biotechnol; 2009 Nov; 144(3):165-6. PubMed ID: 19931092
[No Abstract] [Full Text] [Related]
19. Beyond genomics.
Dollery CT
Clin Pharmacol Ther; 2007 Oct; 82(4):366-70. PubMed ID: 17851575
[TBL] [Abstract][Full Text] [Related]
20. Scientific workflows as productivity tools for drug discovery.
Shon J; Ohkawa H; Hammer J
Curr Opin Drug Discov Devel; 2008 May; 11(3):381-8. PubMed ID: 18428092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
